access+affordability

A new report provides a thorough analysis of the state of personalized oncology utilization across Europe.

Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines.

France will ensure free COVID-19 vaccinations for all in its social security system and has earmarked some 1.5 billion euros ($1.82 billion) of next year’s social security budget to cover the cost.

The contracts are complicated and full of risks for drug companies. But there's also a risk to steering clear of the arrangements -- reduced or restricted access to a company's medication.

Gilead’s remdesivir is overpriced at $3,000, group says.

Athletes, politicians, and other wealthy or well-connected people have managed to get special treatment throughout the pandemic, including preferential access to testing and unapproved therapies.

The continent of 1.3 billion people has recorded more than 2.2 million confirmed coronavirus infections.

The Need for a Global Approach

The company is expected to release the results from the Phase I/II clinical trials this month.

Planned changes to the guidelines of Canada’s Patented Medicine Prices Review Board (PMPRB) could make vital treatments harder to get, says a Calgary woman living with a rare blood disorder.

Florida has moved the farthest in developing a drug importation program.

STAT+ Conversations

Canada's decision to block American imports of certain prescription drugs from north of the border is getting stony silence from the Trump administration -- a sign, one expert says, that the U.S. proposal is "dead in the water."

How much is a life worth?

Cancer societies and the Norwegian Ministry of Health and Care Services officially launched the long-awaited European Fair Pricing Network (EFPN).